MRNA Apr 2024 175.000 call
| Previous close | 26.05 |
| Open | 26.35 |
| Bid | 22.75 |
| Ask | 24.85 |
| Strike | 175.00 |
| Expiry date | 2024-04-19 |
| Day's range | 26.00 - 26.35 |
| Contract range | N/A |
| Volume | |
| Open interest | 43 |
- Yahoo Finance
Moderna's Bancel defends COVID-19 vaccine price at Sanders hearing
Moderna's CEO Stéphane Bancel faced off with Sen. Bernie Sanders and others of the Senate HELP committee to defend raising the COVID vaccine price for the commercial market.
- Zacks
Moderna (MRNA) Outpaces Stock Market Gains: What You Should Know
Moderna (MRNA) closed the most recent trading day at $149.42, moving +0.84% from the previous trading session.
- GlobeNewswire
Moderna and Generation Bio Announce Strategic Collaboration to Develop Non-Viral Genetic Medicines
Collaboration will extend the applications of each company’s platform through discovery and development of novel lipid nanoparticles using Generation Bio’s proprietary stealth cell-targeted lipid nanoparticle (ctLNP) delivery system Moderna has acquired an option to license Generation Bio’s ctLNP and closed-ended DNA (ceDNA) technology for two immune cell programs and two liver programs, with an additional option for a third immune cell or liver program Moderna will fund all research and develop
